Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'fludarabine' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 554 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Singer, CRJ; Goldstone, T
      Chronic lymphocytic leukaemia

      CLINICAL MEDICINE
    2. Wautier, JL; Rouger, P
      Drug induced hemolytic anemia

      TRANSFUSION CLINIQUE ET BIOLOGIQUE
    3. Porter, DL; Luger, SM; Duffy, KM; Stadtmauer, EA; Laport, G; Schuster, SJ; Orloff, G; Tsai, D; McDaid, K; Kathakali, A; Leonard, DGB; Antin, JH
      Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    4. Harvey, S; Decker, R; Dal, Y; Schaefer, G; Tang, L; Kramer, L; Dent, P; Grant, S
      Interactions between 2-fluoroadenine 9-beta-d-arabinofuranoside and the kinase inhibitor UCN-01 in human leukemia and lymphoma cells

      CLINICAL CANCER RESEARCH
    5. Wall, NR; Beck, FWJ; Al-Katib, AM; Mohammad, RM
      Treatment-induced expression of anti-apoptotic proteins in WSU-CLL, a human chronic lymphocytic leukemia cell line

      JOURNAL OF DRUG TARGETING
    6. Nguyen, Q; Estey, E; Raad, I; Rolston, K; Kantarjian, H; Jacobson, K; Konoplev, S; Ghosh, S; Luna, M; Tarrand, J; Whimbey, E
      Cytomegalovirus pneumonia in adults with leukemia: An emerging problem

      CLINICAL INFECTIOUS DISEASES
    7. Cohen, BJ; Moskowitz, C; Straus, D; Noy, A; Hedrick, E; Zelenetz, A
      Phosphamide/fludarabine (CF) is active in the treatment of mantle cell lymphoma

      LEUKEMIA & LYMPHOMA
    8. Hogan, WJ; Edwards, WD; Macon, WR; Habermann, TM
      Fulminant hepatic failure secondary to adenovirus following fludarabine-based chemotherapy for non-Hodgkin's lymphoma

      LEUKEMIA & LYMPHOMA
    9. McBride, NC; Cavenagh, JD; Ward, MC; Grant, I; Schey, S; Gray, A; Hughes, A; Mills, MJ; Cervi, P; Newland, AC; Kelsey, SM
      Liposomal daunorubicin (daunoxome) in combination with cyclophosphamide, vincristine and prednisolone (COPA) as salvage therapy in poor-prognosis non-Hodgkins lymphoma

      LEUKEMIA & LYMPHOMA
    10. Robak, T; Blonski, JZ; Kasznicki, M
      Does intensive treatment with high dose chlorambucil and prednisone as first line and cladribine as second line influence the survival of the patients with chronic lymphocytic leukemia?

      LEUKEMIA & LYMPHOMA
    11. Vidarsson, B; Abonour, R; Williams, EC; Woodson, RD; Turman, NJ; Kim, K; Mosher, DF; Wiersma, SR; Longo, WL
      Fludarabine and cytarabine as a sequential infusion regimen for treatment of adults with recurrent, refractory or poor prognosis acute leukemia

      LEUKEMIA & LYMPHOMA
    12. Tinmouth, A; Zanke, B; Imrie, KR
      Fludarabine in alkylator-resistant follicular non-Hodgkin's lymphoma

      LEUKEMIA & LYMPHOMA
    13. Chatterjee, R; Kottaridis, PD; McGarrigle, H; Goldstone, AH
      Reversal of fludarabine induced testicular damage in a patient with chronic lymphocytic leukaemia (CLL), by suppression of pituitary-testicular axis using Gonadotrophin releasing hormone (GnRH)

      LEUKEMIA & LYMPHOMA
    14. Van den Neste, E; Delannoy, A; Feremans, W; Ferrant, A; Michaux, L
      Second primary tumors and immune phenomena after fludarabine or 2-chloro-2'-deoxyadenosine treatment

      LEUKEMIA & LYMPHOMA
    15. Robak, T
      Cladribine in the treatment of chronic lymphocytic leukemia

      LEUKEMIA & LYMPHOMA
    16. Montefusco, E; Fazi, F; Cordone, I; Ariola, C; Nanni, M; Spadea, A; Spiriti, MAA; Fenu, S; Mandelli, F; Petti, MC
      Molecular remission following high-dose hydroxyurea and fludarabine plus cytarabine in a patient with simultaneous acute myeloid leukemia and low-grade lymphoma

      LEUKEMIA & LYMPHOMA
    17. Clavio, M; Gatto, S; Beltrami, G; Cerri, R; Carrara, P; Pierri, I; Canepa, L; Miglino, M; Balleari, E; Masoudi, B; Damasio, E; Ghio, R; Sessarego, M; Gobbi, M
      First line therapy with fludarabine combinations in 42 patients with either post myelodysplastic syndrome or therapy related acute myeloid leukaemia

      LEUKEMIA & LYMPHOMA
    18. Gregory, SA; Vose, J; Modiano, M; Kraemer, K; Rifkin, R; Rubin, A; Menduni, T; Ghalie, R
      Mitoxantrone and fludarabine in the treatment of patients with non-Hodgkin's lymphoma failing primary therapy with a doxorubicin- or mitoxantrone-containing regimen

      LEUKEMIA & LYMPHOMA
    19. Russo, D; Pricolo, G; Michieli, M; Michelutti, A; Raspadori, D; Bertone, A; Marin, L; Pierri, I; Bucalossi, A; Zuffa, E; De Vivo, A; Mazza, P; Gobbi, M; Lauria, F; Zaccaria, A; Baccarani, M
      Fludarabine, arabinosyl cytosine and idarubicin (FLAI) for remission induction in poor-risk acute myeloid leukemia

      LEUKEMIA & LYMPHOMA
    20. Slavin, S; Nagler, A; Shapira, M; Panigrahi, S; Samuel, S; Or, A
      Non-myeloablative allogeneic stem cell transplantation focusing on immunotherapy of life-threatening malignant and non-malignant diseases

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    21. Colombo, P; Gunnarsson, K; Iatropoulos, M; Brughera, M
      Toxicological testing of cytotoxic drugs (Review)

      INTERNATIONAL JOURNAL OF ONCOLOGY
    22. Heider, A; Niederle, N
      Efficacy and toxicity of bendamustine in patients with relapsed low-grade non-Hodgkin's lymphomas

      ANTI-CANCER DRUGS
    23. Czuczman, MS
      Combination chemotherapy and rituximab

      ANTI-CANCER DRUGS
    24. Samonis, G; Kontoyiannis, DP
      Infectious complications of purine analog therapy

      CURRENT OPINION IN INFECTIOUS DISEASES
    25. Alessandrino, EP; Bernasconi, P; Colombo, AA; Caldera, D; Bonfichi, M; Pagnucco, G; Malcovati, L; Varettoni, M; Lazzarino, M; Bernasconi, C
      Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant

      ANNALS OF HEMATOLOGY
    26. Ng, HJ; Lim, LC
      Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: case report

      ANNALS OF HEMATOLOGY
    27. Kern, W; Schleyer, E; Braess, J; Wittmer, E; Ohnesorge, J; Unterhalt, M; Wormann, B; Buchner, T; Hiddemann, W
      Efficacy of fludarabine, intermittent sequential high-dose cytosine arabinoside, and mitoxantrone [FIS-HAM] salvage therapy in highly resistant acuteleukemias

      ANNALS OF HEMATOLOGY
    28. Churn, M; Clough, V
      Autoimmune thrombocytopenia associated with the first cycle of fludarabinetherapy in the treatment of relapsed non-Hodgkin's lymphoma

      CLINICAL ONCOLOGY
    29. Wong, SSY; Woo, PCY; Yuen, KY
      Candida tropicalis and Penicillium marneffei mixed fungaemia in a patient with Waldenstrom's macroglobulinaemia

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    30. Seymour, JF; Grigg, AP; Szer, J; Fox, RM
      Fludarabine and mitoxantrone: Effective and well-tolerated salvage therapyin relapsed indolent lymphoproliferative disorders

      ANNALS OF ONCOLOGY
    31. Robak, T; Gora-Tybor, J; Lech-Maranda, E; Blonski, JZ; Robak, T
      Cladribine in combination with mitoxantrone and cyclophosphamide (CMC) in the treatment of heavily pre-treated patients with advanced indolent lymphoid malignancies

      EUROPEAN JOURNAL OF HAEMATOLOGY
    32. Joyce, RM; Kraser, CN; Tetrealt, JC; Giallombardo, N; McDermott, D; Levine, J; Umiel, T; Regan, M; Hurley, D; Uhl, L; Avigan, D
      Rituximab and ifosfamide, mitoxantrone, etoposide (RIME) with Neupogen (R)support for B-cell non-Hodgkin's lymphoma prior to high-dose chemotherapy with autologous haematopoietic transplant

      EUROPEAN JOURNAL OF HAEMATOLOGY
    33. van Besien, K; Keralavarma, B; Devine, S; Stock, W
      Allogeneic and autologous transplantation for chronic lymphocytic leukemia

      LEUKEMIA
    34. Tefferi, A; Li, CY; Reeder, CB; Geyer, SM; Allmer, C; Levitt, R; Michalak, JC; Addo, F; Krook, JE; Witzig, TE; Schaefer, PL; Mailliard, JA
      A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia

      LEUKEMIA
    35. Esteve, J; Villamor, N; Colomer, D; Cervantes, F; Campo, E; Carreras, E; Montserrat, E
      Stem cell transplantation for chronic lymphocytic leukemia: different outcome after autologous and allogeneic transplantation and correlation with minimal residual disease status

      LEUKEMIA
    36. Robak, T; Blonski, JZ; Kasznicki, M; Gora-Tybor, J; Dwilewicz-Trojaczek, J; Boguradzki, P; Konopka, L; Ceglarek, B; Sulek, J; Kuliczkowski, K; Wolowiec, D; Stella-Holowiecka, B; Skotnicki, AB; Nowak, W; Moskwa-Sroka, B; Dmoszynska, A; Calbecka, M
      Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemia

      LEUKEMIA
    37. Ahlmann, M; Lanvers, C; Lumkemann, K; Rossig, C; Freund, A; Baumann, M; Boos, J
      Modulation of ara-CTP levels by fludarabine and hydroxyurea in leukemic cells

      LEUKEMIA
    38. Giles, FJ; Cortes, JE; Baker, SD; Thomas, DA; O'Brien, S; Smith, TL; Beran, M; Bivins, C; Jolivet, J; Kantarjian, HM
      Troxacitabine, a novel dioxolane nucleoside analog, has activity in patients with advanced leukemia

      JOURNAL OF CLINICAL ONCOLOGY
    39. Clavio, M; Quintino, S; Venturino, C; Ballerini, F; Varaldo, R; Gatto, S; Galbusera, V; Garrone, A; Grasso, R; Canepa, L; Miglino, M; Pierri, I; Gobbi, M
      Lymphoplasmacytic lymphoma immunocytoma: Towards a disease-targeted treatment?

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    40. Clavio, M; Quintino, S; Masoudi, B; Carrara, S; Cerri, R; Pierri, I; Canepa, L; Miglino, M; Muner, P; Damasio, E; Gobbi, M
      Cost of de novo acute myeloid leukemia induction therapy in adults: Analysis of EORTC-GIMEMA AML10 and FLANG regimens

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    41. Chow, KU; Boehrer, S; Geduldig, K; Krapohl, A; Hoelzer, D; Mitrou, PS; Weidmann, E
      In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustine

      HAEMATOLOGICA
    42. Santini, G; Nati, S; Spriano, M; Gallamini, A; Pierluigi, D; Congiu, AM; Truini, M; Rubagotti, A; Chisesi, T; Vimercati, R; Rossi, E; Sertoli, MR; Mattei, D; Marino, G; Gobbi, M
      Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma

      HAEMATOLOGICA
    43. Liso, V; Molica, S; Capalbo, S; Pogliani, E; Battista, C; Broccia, G; Montillo, M; Cuneo, A; Leoni, P; Specchia, G; Castoldi, G
      Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy

      HAEMATOLOGICA
    44. Niiya, H; Kanda, Y; Saito, T; Ohnishi, T; Kanai, S; Kawana, Y; Kamuo, K; Iizuka, A; Yakushijin, K; Ueda, K; Chizuka, A; Iijima, K; Ohnishi, M; Nakai, K; Makimoto, A; Tanosaki, R; Tobinai, K; Wakasugi, H; Takaue, Y; Mineishi, S
      Early full donor myeloid chimerism after reduced-intensity stem cell transplantation using a combination of fludarabine and busulfan

      HAEMATOLOGICA
    45. Hanel, M; Friedrichsen, K; Hanel, A; Herbst, R; Morgner, A; Neser, S; Nicklisch, M; Teich, M; Ehninger, G; Fiedler, F
      Mito-FLAG as salvage therapy for relapsed and refractory acute myeloid leukemia

      ONKOLOGIE
    46. Weidmann, E; Boehrer, S; Chow, KU; Engels, K; Harder, L; Hinz, T; Janssen, O; Kriener, S; Rummel, MJ; Siebert, R; Kabelitz, D; Hansmann, ML; Hoelzer, D; Mitrou, PS
      Treatment of aggressive, or progressing indolent peripheral T- and NK-cellneoplasias by combination of fludarabine, cyclophosphamide and doxorubicine

      ONKOLOGIE
    47. Byrd, JC; Shinn, C; Willis, CR; Flinn, IW; Lehman, T; Suasville, E; Lucas, D; Gerver, MR
      UCN-01 induces cytotoxicity toward human CLL cells through a p53-independent mechanism

      EXPERIMENTAL HEMATOLOGY
    48. Nagler, A; Aker, M; Or, R; Naparstek, E; Varadi, G; Brautbar, C; Slavin, S
      Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation

      EXPERIMENTAL HEMATOLOGY
    49. Kimby, E; Brandt, L; Nygren, P; Glimelius, B
      A systematic overview of chemotherapy effects in B-cell chronic lymphocytic leukaemia

      ACTA ONCOLOGICA
    50. Kuo, GM; Boumpas, DT; Illei, GG; Yarboro, C; Pucino, F; Burstein, AH
      Fludarabine pharmacokinetics after subcutaneous and intravenous administration in patients with lupus nephritis

      PHARMACOTHERAPY
    51. Devine, SM; Sanborn, R; Jessop, E; Stock, W; Huml, M; Peace, D; Wickrema, A; Yassine, M; Amin, K; Thomason, D; Chen, YH; Devine, H; Maningo, M; van Besien, K
      Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem celltransplant

      BONE MARROW TRANSPLANTATION
    52. Kreiter, S; Winkelmann, N; Schneider, PM; Schuler, M; Fischer, T; Ullmann, AJ; Huber, C; Derigs, HG; Kolbe, K
      Failure of sustained engraftment after non-myeloablative conditioning withlow-dose TBI and T cell-reduced allogeneic peripheral stem cell transplantation

      BONE MARROW TRANSPLANTATION
    53. Classen, CF; Schulz, AS; Sigl-Kraetzig, M; Hoffmann, GF; Simmonds, HA; Fairbanks, L; Debatin, KM; Friedrich, W
      Successful HLA-identical bone marrow transplantation in a patient with PNPdeficiency using busulfan and fludarabine for conditioning

      BONE MARROW TRANSPLANTATION
    54. Ritchie, DS; Seymour, JF; Roberts, AW; Szer, J; Grigg, AP
      Acute left ventricular failure following melphalan and fludarabine conditioning

      BONE MARROW TRANSPLANTATION
    55. Visani, G; Lemoli, RM; Isidori, A; Piccaluga, PP; Martinelli, G; Malagola, M; Gugliotta, L; Bonini, A; Bonifazi, F; Motta, MR; Rizzi, S; Castellani, S; Tura, S
      Double reinforcement with fludarabine/high-dose cytarabine enhances the impact of autologous stem cell transplantation in acute myeloid leukemia patients

      BONE MARROW TRANSPLANTATION
    56. Qamruddin, AO; Oppenheim, BA; Guiver, M; Mutton, KJ; Chopra, R
      Screening for cytomegalovirus (CMV) infection in allogeneic bone marrow transplantation using a quantitative whole blood polymerase chain reaction (PCR) method: analysis of potential risk factors for CMV infection

      BONE MARROW TRANSPLANTATION
    57. Chan, KW; Li, CK; Worth, LL; Chik, KW; Jeha, S; Shing, MK; Yuen, PM
      A fludarabine-based conditioning regimen for severe aplastic anemia

      BONE MARROW TRANSPLANTATION
    58. Phylchenkov, AA; Zavelevich, MP; Butenko, ZA
      Apoptosis induction in human malignant lymphoid cells by DNA-damaging agents with different mechanisms of action

      EXPERIMENTAL ONCOLOGY
    59. Yagci, M; Sucak, GT; Ogur, G; Haznedar, R
      Therapy-related refractory anemia with ringed sideroblasts in chronic lymphocytic leukemia: involvement of 3q21 region

      CANCER GENETICS AND CYTOGENETICS
    60. Andrey, J; Saven, A
      Therapeutic advances in the treatment of hairy cell leukemia

      LEUKEMIA RESEARCH
    61. Misgeld, E; Germing, U; Aul, C; Gattermann, N
      Secondary myelodysplastic syndrome after fludarabine therapy of a low-grade non-Hodgkin's lymphoma

      LEUKEMIA RESEARCH
    62. Horwitz, ME; Barrett, AJ; Brown, MR; Carter, CS; Childs, R; Gallin, JI; Gress, RE; Holland, SM; Linton, GF; Miller, JA; Leitman, SF; Read, EJ; Schermerhorn, J; Malech, HL
      Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft.

      NEW ENGLAND JOURNAL OF MEDICINE
    63. Azuma, A; Huang, P; Matsuda, A; Plunkett, W
      2 '-C-cyano-2 '-deoxy-1-beta-D-arabino-pentofuranosylcytosine: A novel anticancer nucleoside analog that causes both DNA strand breaks and G(2) arrest

      MOLECULAR PHARMACOLOGY
    64. Batlle, M; Ribera, JM; Oriol, A; Rodriguez, L; Cirauqui, B; Xicoy, B; Grau, J; Feliu, J; Flores, A; Milla, F
      Pneumonias in patients with chronic lymphocytic leukemia. Study of 30 episodes

      MEDICINA CLINICA
    65. Afenya, EK
      Recovery of normal hemopoiesis in disseminated cancer therapy - a model

      MATHEMATICAL BIOSCIENCES
    66. Gallardo, E; De Andres, I; Illa, I
      Cathepsins are upregulated by IFN-gamma/STAT1 in human muscle culture: A possible active factor in dermatomyositis

      JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    67. Persidsky, Y; Limoges, J
      HIV-1 infection: new treatment paradigms

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    68. Fraternale, A; Casabianca, A; Tonelli, A; Chiarantini, L; Brandi, G; Magnani, M
      New drug combinations for the treatment of murine AIDS and macrophage protection

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    69. Cortes, J; O'Brien, S; Loscertales, J; Kantarjian, H; Giles, F; Thomas, D; Koller, C; Keating, M
      Cyclosporin A for the treatment of cytopenia associated with chronic lymphocytic leukemia

      CANCER
    70. Bornhauser, M; Kiehl, M; Siegert, W; Schetelig, J; Hertenstein, B; Martin, H; Schwerdtfeger, R; Sayer, HG; Runde, V; Kroger, N; Theuser, C; Ehninger, G
      Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysis

      BRITISH JOURNAL OF HAEMATOLOGY
    71. Di Gaetano, N; Xiao, Y; Erba, E; Bassan, R; Rambaldi, A; Golay, J; Introna, M
      Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the, cytotoxic activity of either drug alone

      BRITISH JOURNAL OF HAEMATOLOGY
    72. Hallek, M; Schmitt, B; Wilhelm, M; Busch, R; Krober, A; Fostitsch, HP; Sezer, O; Herold, M; Knauf, W; Wendtner, CM; Kuse, R; Freund, M; Franke, A; Schriever, F; Nerl, C; Dohner, H; Thiel, E; Hiddemann, W; Brittinger, G; Emmerich, B
      Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia, (CLL): results of a phase II study of the German CLL Study Group

      BRITISH JOURNAL OF HAEMATOLOGY
    73. Dumontet, C; Morschhauser, F; Solal-Celigny, P; Bouafia, F; Bourgeois, E; Thieblemont, C; Leleu, X; Hequet, O; Salles, G; Coiffier, B
      Gemcitabine as a single agent in the treatment of relapsed or refractory low-grade non-Hodgkin's lymphoma

      BRITISH JOURNAL OF HAEMATOLOGY
    74. Robak, T; Kasznicki, M; Blonski, JZ; Dmoszynska, A; Skotnicki, AB
      Pure red cell aplasia in patients with chronic lymphocytic leukaemia treated with cladribine

      BRITISH JOURNAL OF HAEMATOLOGY
    75. Lagneaux, L; Delforge, A; Carlier, S; Massy, M; Bernier, M; Bron, D
      Early induction of apoptosis in B-chronic lymphocytic leukaemia cells by hydroxychloroquine: activation of caspase-3 and no protection by survival factors

      BRITISH JOURNAL OF HAEMATOLOGY
    76. Patriarca, F; Silvestri, F; Fanin, R; Zaja, F; Sperotto, A; Baccarani, M
      Long-lasting complete remission of hepatitis C virus (HCV) infection and HCV-associated immunocytoma with alpha-interferon treatment

      BRITISH JOURNAL OF HAEMATOLOGY
    77. McCloy, M; Almeida, A; Daly, P; Vulliamy, T; Roberts, IAG; Dokal, I
      Fludarabine-based stem cell transplantation protocol for Fanconi's anaemiain myelodysplastic transformation

      BRITISH JOURNAL OF HAEMATOLOGY
    78. Ahn, JH; Lee, KH; Lee, JH; Lee, JS; Park, CJ; Chi, HS; Kim, WK
      A case of refractory idiopathic pure red cell aplasia responsive to fludarabine treatment

      BRITISH JOURNAL OF HAEMATOLOGY
    79. Jackson, G; Taylor, P; Smith, GM; Marcus, R; Smith, A; Chu, P; Littlewood, TJ; Duncombe, A; Hutchinson, M; Mehta, AB; Johnson, SA; Carey, P; Mackie, MJ; Ganly, PS; Turner, GE; Deane, M; Schey, S; Brookes, J; Tollerfield, SM; Wilson, MP
      A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformation

      BRITISH JOURNAL OF HAEMATOLOGY
    80. Gooptu, C; Littlewood, TJ; Frith, P; Lyon, CC; Carmichael, AJ; Oliwiecki, S; MacWhannell, A; Amagai, M; Hashimoto, T; Dean, D; Allen, J; Wojnarowska, F
      Paraneoplastic pemphigus: an association with fludarabine?

      BRITISH JOURNAL OF DERMATOLOGY
    81. Scarisbrick, JJ; Child, FJ; Clift, A; Sabroe, R; Whittaker, SJ; Spittle, M; Russell-Jones, R
      A trial of fludarabine and cyclophosphamide combination chemotherapy in the treatment of advanced refractory primary cutaneous T-cell lymphoma

      BRITISH JOURNAL OF DERMATOLOGY
    82. Carbone, GMR; Catapano, CV; Fernandes, DJ
      Imbalanced DNA synthesis induced by cytosine arabinoside and fludarabine in human leukemia cells

      BIOCHEMICAL PHARMACOLOGY
    83. Barta, A; Denes, R; Masszi, T; Remenyi, P; Batai, A; Torbagyi, E; Sipos, A; Lengyel, L; Jakab, K; Gyodi, E; Reti, M; Foldi, J; Paldi-Haris, P; Avalos, M; Paloczi, K; Fekete, S; Torok, J; Hoffer, I; Jakab, J; Varadi, G; Kelemen, E; Petranyi, G
      Remarkably reduced transplant-related complications by dibromomannitol non-myeloablative conditioning before allogeneic bone marrow transplantation in chronic myeloid leukemia

      ACTA HAEMATOLOGICA
    84. Stotzer, OJ; Schleuning, M; Ledderose, G; Hiddemann, W; Kolb, HJ
      Allogeneic transplantation in malignant lymphoma

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    85. Hallek, M; Schmitt, B; Emmerich, B; Stein, H
      Chronic lymphocytic leukemia - Part 2: Treatment

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    86. Fraternale, A; Casabianca, A; Tonelli, A; Vallanti, G; Chiarantini, L; Brandi, G; Celeste, AG; Magnani, M
      Inhibition of murine AIDS by alternate administration of azidothymidine and fludarabine monophosphate

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    87. Fraternale, A; Tonelli, A; Casabianca, A; Chiarantini, L; Schiavano, GF; Celeste, AG; Magnani, M
      New treatment protocol including lympholytic and antiretroviral drugs to inhibit murine AIDS

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    88. Schlegel, PJ; Samlowski, WE; Ward, JH
      Autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemiaand renal cell carcinoma after treatment with high-dose intravenous bolus interleukin-2

      JOURNAL OF IMMUNOTHERAPY
    89. Husebekk, A; Fellowes, V; Read, EJ; Williams, J; Petrus, MJ; Gress, RE; Fowler, DH
      Selection and expansion of T cells from untreated patients with CLL: source of cells for immune reconstitution?

      CYTOTHERAPY
    90. Rodriguez, CO; Plunkett, W; Paff, MT; Du, M; Nowak, B; Ramakrishna, P; Keating, MJ; Gandhi, V
      High-performance liquid chromatography method for the determination and quantitation of arabinosylguanine triphosphate and fludarabine triphosphate in human cells

      JOURNAL OF CHROMATOGRAPHY B
    91. Ladetto, M; Bergui, L; Ricca, I; Campana, S; Pileri, A; Tarella, C
      Rituximab anti-CD20 monoclonal antibody induces marked but transient reductions of peripheral blood lymphocytes in chronic lymphocytic leukaemia patients

      MEDICAL ONCOLOGY
    92. Pangalis, GA; Dimopoulou, MN; Angelopoulou, MK; Tsekouras, CH; Siakantaris, MP
      Campath-1H in B-chronic lymphocytic leukemia: report on a patient treated thrice in a 3 year period

      MEDICAL ONCOLOGY
    93. Marks, DI; Bird, JM; Vettenranta, K; Hunt, L; Green, A; Cornish, JM; Goulden, N; Pamphilon, DH; Steward, CG; Oakhill, A
      T cell-depleted unrelated donor bone marrow transplantation for acute myeloid leukemia

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    94. Petrus, MJ; Williams, JF; Eckhaus, MA; Gress, RE; Fowler, DH
      An immunoablative regimen of fludarabine and cyclophosphamide prevents fully MHC-mismatched murine marrow graft rejection independent of GVHD

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    95. Yang, LY; Li, L; Jiang, H; Shen, Y; Plunkett, W
      Expression of ERCC1 antisense RNA abrogates gemcitabine-mediated cytotoxicsynergism with cisplatin in human colon tumor cells defective in mismatch repair but proficient in nucleotide excision repair

      CLINICAL CANCER RESEARCH
    96. Kapelushnik, J; Mandel, H; Varadi, G; Nagler, A
      Fludarabine-based protocol for haploidentical peripheral blood stem cell transplantation in Hurler syndrome

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    97. Vu, UE; Pavletic, ZS; Wang, XJ; Joshi, SS
      Increased cytotoxicity against B-chronic lymphocytic leukemia by cellular manipulations: Potentials for therapeutic use

      LEUKEMIA & LYMPHOMA
    98. Grigg, A; Clarke, K; Szer, J
      Prolonged disease-free survival after autografting for chemosensitive non-bulky low grade non-Hodgkin's Lymphoma

      LEUKEMIA & LYMPHOMA
    99. Robak, T; Wrzesien-Kus, A; Lech-Maranda, E; Kowal, M; Dmoszynska, A
      Combination regimen of cladribine (2-chlorodeoxyadenosine), cytarabine andG-CSF (CLAG) as induction therapy for patients with relapsed or refractoryacute myeloid leukemia

      LEUKEMIA & LYMPHOMA
    100. Barresi, GM; Albitar, M; O'Brien, SM
      Acute myeloid leukemia, inversion 16, occurring in a patient with chronic lymphocytic leukemia

      LEUKEMIA & LYMPHOMA


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/08/20 alle ore 00:56:02